ClinicalTrials.govpublic full text
UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
real world multi-cohort study of patients with non-small cell lung cancer (nsclc) initiating approved drugs developed by az or as part of an az alliance, observational, real world study, rwe, non-small cell lung cancer, multi-cohort, ambispective, prospective, retrospective, durvalumab, osimertinib, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 892918
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.